MarketsStocksAARTIPHARM
AA

Aarti Pharmalabs Ltd

NSE: AARTIPHARMBSE: 543748Healthcare
Download Research Report7-page PDF
605.05
-3.70%
NSE · auto-updates while market open
Prev Close
₹909.25
Day High
₹621.70
Day Low
₹604.15
Mkt Cap
₹5,335 Cr
P / E
28.6
P / B
2.5
ROE
9.1%
52W High
₹971.00
52W Low
₹585.00
Key Metrics
Market Cap
₹5,335 Cr
P / E
28.60
P / B
2.51
EV / EBITDA
17.39
ROCE
11.1%
ROE
9.1%
Debt / Equity
0.32
Book Value
₹234.35
EPS
₹19.27
Div Yield
0.6%
Face Value
₹5
Promoter Holding
43.1%
Revenue · ₹ Cr
1.9k
FY23
1.9k
FY24
2.1k
FY25
1.8k
FY26
Net Profit · ₹ Cr
193
FY23
217
FY24
272
FY25
175
FY26
EPS · ₹ per share
₹21.4
FY23
₹23.9
FY24
₹30.1
FY25
₹19.3
FY26
P / E Ratio · price ÷ TTM EPS
1021314234160-2Mar 23Apr 24May 25Jun 26
P/E 29.5×Median 25.1×TTM EPS
Q1 2026 snapshot
Sales
₹591 Cr
Operating profit
-
OPM
-
Net profit
₹61 Cr
EPS
₹6.74
Scorecard · 7 axes
Quality
Good
63/100
Valuation
Avg
28.6×
Growth
-
Profitability
Avg
10.1%
Performance
Bad
-32.1%
Entry Point
Good
62%
Red Flags
Strong
0 flags
Shareholding Pattern
43.1%Promoter
Promoter43.1%
FII8.4%
DII7.4%
Public41.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue537.778562.17387.79418.39431.9590.7
Net Profit73.98888.34149.50127.92347.95661.124
NPM %13.8%15.7%12.8%6.7%11.1%10.3%
AlertPre-trade